Critical appraisal of nilotinib in frontline treatment of chronic myeloid leukemia

Por DeRemer, David L, Katsanevas, Katerina, Ustun, Celalettin
Publicado em 2011

Anti-angiogenic therapy for cancer: An update

Por Al-Husein, Belal, Abdalla, Maha, Trepte, Morgan, DeRemer, David L., Somanath, Payaningal R.
Publicado em 2012

Plerixafor Salvage Is Safe and Effective in Hard-to-Mobilize Patients Undergoing Chemotherapy and Filgrastim-Based Peripheral Blood Progenitor Cell Mobilization

Por Awan, Farrukh T., Kochuparambil, S. Thomas, DeRemer, David, Cumpston, Aaron, Craig, Michael, Jillella, Anand, Hamadani, Mehdi
Publicado em 2012

Targeting Src-mediated Tyr216 phosphorylation and activation of GSK-3 in prostate cancer cells inhibit prostate cancer progression in vitro and in vivo

Por Goc, Anna, Al-Husein, Belal, Katsanevas, Katerina, Steinbach, Alison, Lou, Uvette, Sabbineni, Harika, DeRemer, David L., Somanath, Payaningal R.
Publicado em 2014